Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

505
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
505
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

507
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
507
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

674
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
674
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

921
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
921
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

331
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
331
Survival Curves01:18

Survival Curves

581
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
581

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Simulation and Case Study to Evaluate the Extrapolation Performance of Flexible Bayesian Survival Models when Incorporating Real-World Data.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same author

Can we develop prognostic models for estimating life expectancy following a cancer diagnosis? Evaluating model complexity, data requirements, and optimal modelling frameworks.

Cancer epidemiology·2026
Same author

Evaluating the Impact of Different Natural History Modeling Methods on Cost-Effectiveness Decisions: A Case Study in Duchenne Muscular Dystrophy.

MDM policy & practice·2026
Same author

International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study.

The Lancet. Oncology·2026
Same author

Estimating the impact of cancer diagnosis on life expectancy by stage at diagnosis: population-based estimates for a range of cancer sites in England.

BMJ oncology·2026
Same author

Risk of colorectal cancer by socioeconomic position and history of mental illness - a national nested case-control study.

BMC cancer·2026

Related Experiment Video

Updated: Dec 30, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Marginal measures and causal effects using the relative survival framework.

Elisavet Syriopoulou1, Mark J Rutherford1, Paul C Lambert1,2

  • 1Biostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, UK.

International Journal of Epidemiology
|January 19, 2020
PubMed
Summary

Relative survival analysis provides marginal estimates to compare cancer patient prognosis across groups. This method helps quantify differences and estimate avoidable deaths, improving understanding of cancer survival disparities.

Keywords:
Relative survivalavoidable deathscausal effectsmarginal measures

More Related Videos

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.8K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

Related Experiment Videos

Last Updated: Dec 30, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.8K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Cancer Research

Background:

  • Cancer survival studies often focus on death due to cancer, but competing events complicate analysis.
  • Relative survival is a key measure, addressing inaccuracies in cause of death data.
  • Marginal estimates of relative survival offer insights into cancer population prognosis and subgroup differences.

Purpose of the Study:

  • To apply regression standardization within a relative survival framework for marginal estimates.
  • To explore differences between exposure groups using standardized measures and contrasts.
  • To estimate the impact of eliminating cancer-related disparities and quantify avoidable deaths.

Main Methods:

  • Utilized regression standardization to derive marginal estimates in relative survival.
  • Calculated standardized relative survival, all-cause survival, and crude probabilities of death.
  • Formed contrasts to assess group differences, interpreted as causal effects under assumptions.

Main Results:

  • Estimated various marginal measures and contrasts using relative survival.
  • Differentiated between analyses focusing solely on cancer-related differences versus those including other causes.
  • Quantified the impact of eliminating inter-group differences and estimated potential avoidable deaths.

Conclusions:

  • Marginal estimates in relative survival offer valuable summary measures.
  • These methods enhance the understanding of differences across various exposure groups in cancer survival.
  • The approach is applicable to real-world scenarios, such as analyzing socio-economic disparities in colon cancer survival.